GSK Annual Revenue
$37.74 B
+$1.42 B+3.92%
31 December 2023
Summary:
As of January 20, 2025, GSK annual revenue is $37.74 billion, with the most recent change of +$1.42 billion (+3.92%) on December 31, 2023. During the last 3 years, it has risen by +$6.48 billion (+20.73%). GSK annual revenue is now -17.07% below its all-time high of $45.51 billion, reached on December 31, 2007.GSK Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GSK Quarterly Revenue
$10.43 B
+$478.26 M+4.81%
30 September 2024
Summary:
As of January 20, 2025, GSK quarterly revenue is $10.43 billion, with the most recent change of +$478.26 million (+4.81%) on September 30, 2024. Over the past year, it has increased by +$425.06 million (+4.25%). GSK quarterly revenue is now -21.15% below its all-time high of $13.22 billion, reached on December 31, 2009.GSK Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GSK TTM Revenue
$39.71 B
+$109.21 M+0.28%
30 September 2024
Summary:
As of January 20, 2025, GSK TTM revenue is $39.71 billion, with the most recent change of +$109.21 million (+0.28%) on September 30, 2024. Over the past year, it has increased by +$1.96 billion (+5.20%). GSK TTM revenue is now -14.15% below its all-time high of $46.26 billion, reached on March 31, 2010.GSK TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GSK Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.9% | +4.3% | +5.2% |
| 3 y3 years | +20.7% | +8.1% | +8.8% |
| 5 y5 years | -8.2% | +8.1% | +8.8% |
GSK Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +11.1% | at high | +23.4% | at high | +13.3% |
| 5 y | 5-year | -12.4% | +20.7% | -10.5% | +885.4% | -11.2% | +51.6% |
| alltime | all time | -17.1% | +2739.0% | -21.1% | +885.4% | -14.2% | +7248.1% |
GSK Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $10.43 B(+4.8%) | $39.71 B(+0.3%) |
| June 2024 | - | $9.95 B(+6.5%) | $39.60 B(+2.5%) |
| Mar 2024 | - | $9.34 B(-6.6%) | $38.64 B(+2.4%) |
| Dec 2023 | $37.74 B(+3.9%) | $10.00 B(-3.1%) | $37.75 B(+3.6%) |
| Sept 2023 | - | $10.32 B(+14.8%) | $36.42 B(+3.1%) |
| June 2023 | - | $8.98 B(+6.3%) | $35.32 B(+0.8%) |
| Mar 2023 | - | $8.45 B(-2.6%) | $35.05 B(-3.3%) |
| Dec 2022 | $36.31 B(+6.9%) | $8.67 B(-5.9%) | $36.24 B(-2.3%) |
| Sept 2022 | - | $9.21 B(+5.8%) | $37.11 B(+0.2%) |
| June 2022 | - | $8.71 B(-9.7%) | $37.03 B(+1.5%) |
| Mar 2022 | - | $9.65 B(+1.1%) | $36.48 B(-1.6%) |
| Dec 2021 | $33.98 B(+8.7%) | $9.54 B(+4.4%) | $37.06 B(+41.5%) |
| Sept 2021 | - | $9.14 B(+12.0%) | $26.20 B(-7.2%) |
| June 2021 | - | $8.16 B(-20.2%) | $28.23 B(-4.4%) |
| Mar 2021 | - | $10.23 B(-870.4%) | $29.53 B(-4.6%) |
| Dec 2020 | $31.26 B(-27.5%) | -$1.33 B(-111.9%) | $30.95 B(-29.2%) |
| Sept 2020 | - | $11.17 B(+18.2%) | $43.74 B(-0.9%) |
| June 2020 | - | $9.45 B(-18.9%) | $44.13 B(-1.3%) |
| Mar 2020 | - | $11.65 B(+1.6%) | $44.71 B(+3.9%) |
| Dec 2019 | $43.10 B(+4.8%) | $11.46 B(-0.9%) | $43.04 B(+2.2%) |
| Sept 2019 | - | $11.56 B(+15.2%) | $42.13 B(+2.5%) |
| June 2019 | - | $10.04 B(+0.6%) | $41.10 B(+0.2%) |
| Mar 2019 | - | $9.98 B(-5.4%) | $41.03 B(-0.2%) |
| Dec 2018 | $41.12 B(+5.5%) | $10.55 B(+0.0%) | $41.09 B(+1.0%) |
| Sept 2018 | - | $10.54 B(+5.8%) | $40.69 B(+0.7%) |
| June 2018 | - | $9.96 B(-0.8%) | $40.41 B(+1.5%) |
| Mar 2018 | - | $10.04 B(-1.0%) | $39.81 B(+2.3%) |
| Dec 2017 | $38.98 B(+3.1%) | $10.14 B(-1.2%) | $38.91 B(+1.9%) |
| Sept 2017 | - | $10.27 B(+9.7%) | $38.19 B(+1.0%) |
| June 2017 | - | $9.36 B(+2.3%) | $37.83 B(-0.1%) |
| Mar 2017 | - | $9.15 B(-2.9%) | $37.86 B(+0.6%) |
| Dec 2016 | $37.79 B(+3.4%) | $9.42 B(-4.9%) | $37.63 B(-0.3%) |
| Sept 2016 | - | $9.91 B(+5.6%) | $37.74 B(+1.1%) |
| June 2016 | - | $9.38 B(+5.2%) | $37.33 B(+1.0%) |
| Mar 2016 | - | $8.92 B(-6.5%) | $36.96 B(+1.1%) |
| Dec 2015 | $36.56 B(-3.6%) | $9.53 B(+0.4%) | $36.57 B(-0.7%) |
| Sept 2015 | - | $9.49 B(+5.3%) | $36.82 B(+0.2%) |
| June 2015 | - | $9.02 B(+5.8%) | $36.75 B(-0.9%) |
| Mar 2015 | - | $8.52 B(-12.9%) | $37.09 B(-2.0%) |
| Dec 2014 | $37.92 B(-8.6%) | $9.79 B(+3.8%) | $37.86 B(-3.5%) |
| Sept 2014 | - | $9.43 B(+0.7%) | $39.25 B(-1.7%) |
| June 2014 | - | $9.36 B(+0.8%) | $39.92 B(-2.0%) |
| Mar 2014 | - | $9.29 B(-16.9%) | $40.73 B(-1.8%) |
| Dec 2013 | $41.47 B(-1.0%) | $11.18 B(+10.7%) | $41.49 B(+0.6%) |
| Sept 2013 | - | $10.09 B(-0.7%) | $41.23 B(-0.5%) |
| June 2013 | - | $10.17 B(+1.1%) | $41.44 B(-0.2%) |
| Mar 2013 | - | $10.05 B(-7.9%) | $41.51 B(-0.9%) |
| Dec 2012 | $41.88 B(-4.6%) | $10.92 B(+6.0%) | $41.88 B(-0.1%) |
| Sept 2012 | - | $10.31 B(+0.7%) | $41.93 B(-2.6%) |
| June 2012 | - | $10.23 B(-1.9%) | $43.06 B(-1.7%) |
| Mar 2012 | - | $10.43 B(-4.9%) | $43.80 B(-0.3%) |
| Dec 2011 | $43.92 B(+0.3%) | $10.96 B(-4.1%) | $43.92 B(-0.9%) |
| Sept 2011 | - | $11.44 B(+4.3%) | $44.32 B(+2.0%) |
| June 2011 | - | $10.96 B(+3.9%) | $43.43 B(+1.1%) |
| Mar 2011 | - | $10.55 B(-7.2%) | $42.94 B(-2.1%) |
| Dec 2010 | $43.77 B(-1.5%) | $11.37 B(+7.7%) | $43.87 B(-4.1%) |
| Sept 2010 | - | $10.55 B(+0.8%) | $45.72 B(-1.1%) |
| June 2010 | - | $10.47 B(-8.7%) | $46.25 B(-0.0%) |
| Mar 2010 | - | $11.47 B(-13.2%) | $46.26 B(+3.9%) |
| Dec 2009 | $44.43 B(-1.3%) | $13.22 B(+19.3%) | $44.52 B(+5.7%) |
| Sept 2009 | - | $11.08 B(+5.8%) | $42.11 B(-0.1%) |
| June 2009 | - | $10.48 B(+7.7%) | $42.14 B(-2.5%) |
| Mar 2009 | - | $9.73 B(-10.0%) | $43.24 B(-3.4%) |
| Dec 2008 | $45.04 B(-1.0%) | $10.81 B(-2.8%) | $44.76 B(-3.1%) |
| Sept 2008 | - | $11.12 B(-4.0%) | $46.21 B(+0.1%) |
| June 2008 | - | $11.58 B(+3.0%) | $46.15 B(+0.7%) |
| Mar 2008 | - | $11.24 B(-8.3%) | $45.84 B(+0.7%) |
| Dec 2007 | $45.51 B(+6.3%) | $12.26 B(+10.8%) | $45.53 B(+1.9%) |
| Sept 2007 | - | $11.07 B(-1.8%) | $44.68 B(+1.1%) |
| June 2007 | - | $11.27 B(+3.1%) | $44.18 B(+1.5%) |
| Mar 2007 | - | $10.93 B(-4.2%) | $43.55 B(+1.8%) |
| Dec 2006 | $42.80 B(+8.6%) | $11.41 B(+7.9%) | $42.80 B(+2.6%) |
| Sept 2006 | - | $10.57 B(-0.6%) | $41.70 B(+1.9%) |
| June 2006 | - | $10.63 B(+4.5%) | $40.92 B(+2.3%) |
| Mar 2006 | - | $10.18 B(-1.3%) | $40.01 B(+1.7%) |
| Dec 2005 | $39.40 B(+7.6%) | $10.31 B(+5.3%) | $39.35 B(+1.4%) |
| Sept 2005 | - | $9.79 B(+0.7%) | $38.80 B(+2.2%) |
| June 2005 | - | $9.72 B(+2.1%) | $37.97 B(+2.0%) |
| Mar 2005 | - | $9.52 B(-2.4%) | $37.23 B(+1.6%) |
| Dec 2004 | $36.61 B | $9.76 B(+8.9%) | $36.62 B(+1.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2004 | - | $8.96 B(-0.2%) | $36.00 B(+0.5%) |
| June 2004 | - | $8.98 B(+0.7%) | $35.84 B(+1.0%) |
| Mar 2004 | - | $8.92 B(-2.4%) | $35.48 B(+1.3%) |
| Dec 2003 | $35.02 B(+9.9%) | $9.14 B(+3.9%) | $35.02 B(+0.7%) |
| Sept 2003 | - | $8.80 B(+2.1%) | $34.79 B(+3.0%) |
| June 2003 | - | $8.62 B(+1.9%) | $33.77 B(+2.1%) |
| Mar 2003 | - | $8.46 B(-5.1%) | $33.07 B(+3.7%) |
| Dec 2002 | $31.88 B(+7.8%) | $8.91 B(+14.6%) | $31.89 B(+2.4%) |
| Sept 2002 | - | $7.78 B(-1.8%) | $31.15 B(+1.9%) |
| June 2002 | - | $7.92 B(+8.6%) | $30.55 B(+2.1%) |
| Mar 2002 | - | $7.29 B(-10.7%) | $29.91 B(+1.2%) |
| Dec 2001 | $29.58 B(+7.9%) | $8.17 B(+13.7%) | $29.57 B(+3.1%) |
| Sept 2001 | - | $7.18 B(-1.3%) | $28.69 B(+2.3%) |
| June 2001 | - | $7.28 B(+4.8%) | $28.05 B(+1.2%) |
| Mar 2001 | - | $6.95 B(-4.6%) | $27.71 B(+1.4%) |
| Dec 2000 | $27.40 B(+99.5%) | $7.28 B(+11.2%) | $27.33 B(+15.0%) |
| Sept 2000 | - | $6.55 B(-5.6%) | $23.77 B(+13.9%) |
| June 2000 | - | $6.94 B(+5.6%) | $20.87 B(+20.5%) |
| Mar 2000 | - | $6.57 B(+76.8%) | $17.32 B(+23.4%) |
| Dec 1999 | $13.74 B(+3.8%) | $3.72 B(+1.9%) | $14.04 B(+1.9%) |
| Sept 1999 | - | $3.65 B(+7.6%) | $13.78 B(+1.8%) |
| June 1999 | - | $3.39 B(+3.1%) | $13.53 B(+1.5%) |
| Mar 1999 | - | $3.29 B(-5.0%) | $13.34 B(+0.8%) |
| Dec 1998 | $13.23 B(+1.2%) | $3.46 B(+1.7%) | $13.23 B(+3.2%) |
| Sept 1998 | - | $3.40 B(+6.5%) | $12.83 B(+1.2%) |
| June 1998 | - | $3.19 B(+0.5%) | $12.68 B(-0.8%) |
| Mar 1998 | - | $3.18 B(+4.1%) | $12.78 B(-1.2%) |
| Dec 1997 | $13.07 B(+0.3%) | $3.05 B(-6.1%) | $12.94 B(-16.0%) |
| Sept 1997 | - | $3.25 B(-1.1%) | $15.39 B(-3.8%) |
| June 1997 | - | $3.29 B(-1.4%) | $16.01 B(+0.6%) |
| Mar 1997 | - | $3.34 B(-39.4%) | $15.91 B(+0.5%) |
| Dec 1996 | $13.03 B(-21.3%) | $5.51 B(+42.5%) | $15.82 B(+53.4%) |
| Sept 1996 | - | $3.87 B(+21.3%) | $10.31 B(+14.5%) |
| June 1996 | - | $3.19 B(-2.1%) | $9.01 B(+5.8%) |
| Mar 1996 | - | $3.26 B(+27.0%) | $8.51 B(-18.1%) |
| Dec 1995 | $16.56 B(+61.9%) | - | - |
| Sept 1995 | - | $2.56 B(-4.8%) | $10.40 B(+0.3%) |
| June 1995 | - | $2.69 B(+6.5%) | $10.37 B(+7.4%) |
| June 1995 | $10.23 B(+20.8%) | - | - |
| Mar 1995 | - | $2.53 B(-3.3%) | $9.65 B(+2.9%) |
| Dec 1994 | - | $2.61 B(+3.3%) | $9.38 B(+5.6%) |
| Sept 1994 | - | $2.53 B(+28.2%) | $8.89 B(+5.2%) |
| June 1994 | $8.47 B(+5.6%) | $1.97 B(-12.7%) | $8.45 B(+3.6%) |
| Mar 1994 | - | $2.26 B(+6.6%) | $8.16 B(+0.4%) |
| Dec 1993 | - | $2.12 B(+1.3%) | $8.12 B(+4.0%) |
| Sept 1993 | - | $2.09 B(+24.6%) | $7.81 B(+3.1%) |
| June 1993 | $8.01 B(+11.2%) | $1.68 B(-24.6%) | $7.58 B(+4.8%) |
| Mar 1993 | - | $2.23 B(+23.3%) | $7.23 B(+3.5%) |
| Dec 1992 | - | $1.81 B(-2.9%) | $6.98 B(-0.6%) |
| Sept 1992 | - | $1.86 B(+39.8%) | $7.02 B(-0.2%) |
| June 1992 | $7.21 B(+14.3%) | $1.33 B(-32.9%) | $7.04 B(-5.5%) |
| Mar 1992 | - | $1.98 B(+7.2%) | $7.44 B(+6.7%) |
| Dec 1991 | - | $1.85 B(-1.3%) | $6.97 B(+7.0%) |
| Sept 1991 | - | $1.87 B(+7.8%) | $6.52 B(+8.4%) |
| June 1991 | $6.30 B(+21.8%) | $1.74 B(+14.9%) | $6.01 B(+3.3%) |
| Mar 1991 | - | $1.51 B(+8.7%) | $5.82 B(+3.8%) |
| Dec 1990 | - | $1.39 B(+1.5%) | $5.61 B(+3.7%) |
| Sept 1990 | - | $1.37 B(-11.5%) | $5.41 B(+3.5%) |
| June 1990 | $5.17 B(+17.3%) | $1.55 B(+19.3%) | $5.23 B(+5.3%) |
| Mar 1990 | - | $1.30 B(+8.8%) | $4.96 B(+6.0%) |
| Dec 1989 | - | $1.19 B(+0.5%) | $4.68 B(+4.1%) |
| Sept 1989 | - | $1.19 B(-7.6%) | $4.50 B(+3.9%) |
| June 1989 | $4.41 B(+22.2%) | $1.29 B(+26.2%) | $4.33 B(+2.3%) |
| Mar 1989 | - | $1.02 B(+1.1%) | $4.23 B(+3.8%) |
| Dec 1988 | - | $1.01 B(-1.1%) | $4.08 B(+5.0%) |
| Sept 1988 | - | $1.02 B(-14.4%) | $3.89 B(+4.2%) |
| June 1988 | $3.61 B(+36.0%) | $1.19 B(+37.7%) | $3.73 B(+13.1%) |
| Mar 1988 | - | $863.72 M(+6.1%) | $3.30 B(+4.7%) |
| Dec 1987 | - | $814.42 M(-5.5%) | $3.15 B(+6.1%) |
| Sept 1987 | - | $862.23 M(+13.6%) | $2.97 B(+6.8%) |
| June 1987 | $2.66 B(+29.0%) | $758.67 M(+6.2%) | $2.78 B(+12.3%) |
| Mar 1987 | - | $714.30 M(+12.9%) | $2.47 B(+7.5%) |
| Dec 1986 | - | $632.59 M(-6.0%) | $2.30 B(+3.8%) |
| Sept 1986 | - | $672.76 M(+48.0%) | $2.22 B(+6.3%) |
| June 1986 | $2.06 B(+42.0%) | $454.71 M(-16.1%) | $2.09 B(+27.9%) |
| Mar 1986 | - | $542.04 M(-1.2%) | $1.63 B(+49.8%) |
| Dec 1985 | - | $548.45 M(+1.5%) | $1.09 B(+101.5%) |
| Sept 1985 | - | $540.44 M | $540.44 M |
| June 1985 | $1.45 B(+9.1%) | - | - |
| June 1984 | $1.33 B | - | - |
FAQ
- What is GSK annual revenue?
- What is the all time high annual revenue for GSK?
- What is GSK annual revenue year-on-year change?
- What is GSK quarterly revenue?
- What is the all time high quarterly revenue for GSK?
- What is GSK quarterly revenue year-on-year change?
- What is GSK TTM revenue?
- What is the all time high TTM revenue for GSK?
- What is GSK TTM revenue year-on-year change?
What is GSK annual revenue?
The current annual revenue of GSK is $37.74 B
What is the all time high annual revenue for GSK?
GSK all-time high annual revenue is $45.51 B
What is GSK annual revenue year-on-year change?
Over the past year, GSK annual revenue has changed by +$1.42 B (+3.92%)
What is GSK quarterly revenue?
The current quarterly revenue of GSK is $10.43 B
What is the all time high quarterly revenue for GSK?
GSK all-time high quarterly revenue is $13.22 B
What is GSK quarterly revenue year-on-year change?
Over the past year, GSK quarterly revenue has changed by +$425.06 M (+4.25%)
What is GSK TTM revenue?
The current TTM revenue of GSK is $39.71 B
What is the all time high TTM revenue for GSK?
GSK all-time high TTM revenue is $46.26 B
What is GSK TTM revenue year-on-year change?
Over the past year, GSK TTM revenue has changed by +$1.96 B (+5.20%)